University Bridge Fund I

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

PlasmaBound Ltd. specializes in pre-treatment services for fibre-reinforced composites, utilizing its innovative Controlled Plasma Ablation (CPA) technology. This patent-pending method modifies atmospheric plasma to enhance the adhesive bonding of lightweight materials, such as carbon and glass fibre composites, ensuring that the bonds are stronger than the materials themselves. By improving the structural integrity and reducing the weight of heavy assemblies, PlasmaBound's technology supports various industries, including aerospace, transportation, marine, renewable energy, and consumer electronics. Founded in 2017 and headquartered in Dublin, Ireland, PlasmaBound aims to facilitate the integration of lightweight composite materials into multi-material structural assemblies, thereby advancing manufacturing capabilities.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Tympany Medical focuses on advancing minimally invasive ear surgeries through innovative technology. The company has developed a specialized ear surgery device that provides a sterile endoscopic solution for complex procedures in otolaryngology. This device addresses key challenges related to the usability and flexibility of traditional endoscopes, allowing surgeons to benefit from enhanced visualization while preserving their two-handed operating techniques. By reducing the necessity for mastoidectomies, Tympany Medical aims to improve surgical outcomes and streamline the process of ear surgeries, ultimately enhancing patient care in the field of ENT.

LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. By leveraging advanced four-dimensional imaging and artificial intelligence, LUMA Vision aims to transform electrophysiology and structural heart interventions. Their technology facilitates real-time tissue analysis, enabling healthcare professionals to perform cardiac procedures more effectively. This innovation is designed to improve patient outcomes, enhance procedural safety, and ultimately lower costs within the healthcare system.

TerminusDB is an open-source in-memory graph database management system founded in Dublin, Ireland. It offers a comprehensive platform designed to transform inconsistent data sets into structured and integrated information. TerminusDB features a rich query language, WOQL, and provides a suite of revision control capabilities, including branch, merge, and time-travel functions. The platform facilitates data inference from business objects and relationships while enabling users to define governing rules and automate data migration for analytics. By focusing on structuring data to meet business needs, TerminusDB aims to reduce the complexity of data manipulation and enhance decision-making processes, ultimately supporting increased productivity and efficiency for its users.

Parvalis Therapeutics is a biotechnology company based in Dublin, Ireland, founded in 2020. The company focuses on developing innovative autoimmune therapies for inflammatory diseases and cancer. Parvalis Therapeutics specializes in creating novel immunotherapeutics and conducting research on immunomodulatory compounds. Its mission is to provide effective therapeutic treatments that enhance patient care for those affected by autoimmune disorders and related conditions.

PlasmaBound Ltd. specializes in pre-treatment services for fibre-reinforced composites, utilizing its innovative Controlled Plasma Ablation (CPA) technology. This patent-pending method modifies atmospheric plasma to enhance the adhesive bonding of lightweight materials, such as carbon and glass fibre composites, ensuring that the bonds are stronger than the materials themselves. By improving the structural integrity and reducing the weight of heavy assemblies, PlasmaBound's technology supports various industries, including aerospace, transportation, marine, renewable energy, and consumer electronics. Founded in 2017 and headquartered in Dublin, Ireland, PlasmaBound aims to facilitate the integration of lightweight composite materials into multi-material structural assemblies, thereby advancing manufacturing capabilities.

LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. By leveraging advanced four-dimensional imaging and artificial intelligence, LUMA Vision aims to transform electrophysiology and structural heart interventions. Their technology facilitates real-time tissue analysis, enabling healthcare professionals to perform cardiac procedures more effectively. This innovation is designed to improve patient outcomes, enhance procedural safety, and ultimately lower costs within the healthcare system.

Output Sports Limited, founded in 2018 and based in Dublin, Ireland, specializes in developing wearable sensors aimed at optimizing athlete performance. This sports technology start-up offers a comprehensive solution that leverages advanced signal processing and machine learning to assess various aspects of athletic performance. The company's innovative tool enables sports practitioners to evaluate an athlete's readiness for training, deliver biofeedback, and manage injury risks, all through a single, portable device. Output Sports focuses on providing practical and accurate insights, revolutionizing how athletic staff enhance performance and track training programs.

Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.

AtriAN Medical is an Irish medical device company based in Galway, specializing in innovative treatments for atrial fibrillation. The company has commercialized technology developed at the Mayo Clinic, focusing on a unique approach that utilizes micro Pulsed Electric Fields (mPEF) to selectively ablate hyperactive tissues while preserving surrounding myocardial tissue. AtriAN's device employs a catheter to deliver short pulses of electrical energy to the clusters of neuronal cells responsible for the condition. This method allows for effective treatment without causing damage to the heart muscle, offering physicians a new option in managing atrial fibrillation and improving patient outcomes.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Pharma Latch, a subsidiary of Latch Medical, specializes in innovative drug and vaccine delivery systems that utilize advanced microneedle technology. This approach allows for intradermal delivery, meaning that medications can be administered directly into the skin, enhancing patient comfort and experience. The company has developed a tissue anchor system featuring opposing arrays of angled microneedles, which painlessly penetrate the skin while ensuring consistent delivery depth. This technology aims to improve the effectiveness of drug and vaccine administration and provides healthcare professionals with better alternatives for wound management. Through its core platform technology, Pharma Latch is positioned to make significant advancements in the field of medical delivery systems.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Danalto Limited is a company based in Dublin, Ireland, that specializes in developing and manufacturing Internet of Things (IoT) solutions. Since its incorporation in 2017, Danalto has focused on providing managed services and devices designed to enhance operational efficiency and asset management for businesses. The company offers d-IoT, a managed service that enables enterprises to gain insights into their operational and energy efficiency through the deployment of various sensor devices. These devices measure parameters such as temperature, humidity, and liquid levels, while also including specialized products like d-AlignSpy for monitoring communication link quality and d-GullySpy for flood detection in critical infrastructure. Danalto’s IoT platform integrates tracking capabilities across device, edge, and cloud contexts, catering to sectors such as agriculture, facilities management, transport, and utilities.

Kastus is an award-winning surface innovation company founded in 2014 by John Browne, with its global headquarters and manufacturing based in Ireland. The company specializes in patented surface coating technology designed for glass and ceramics, which was developed to address the growing concerns over antibiotic-resistant infections and the spread of harmful microorganisms. Kastus' ISO-validated coatings have been proven to kill over 99% of bacteria, fungi, and viruses, including human coronavirus, making them particularly effective for enhancing touch hygiene across various products. In response to the COVID-19 pandemic, Kastus introduced antiviral and antimicrobial screen protectors to help businesses safely reopen from lockdown. The company continues to pursue innovative solutions to combat infection risks in indoor environments, backed by recent EU funding aimed at developing new protective technologies.

Coras specializes in enhancing ancillary revenue for various airlines, including Ryanair, Lufthansa, Wizz Air, and Air Asia, operating in over 50 countries and 350 cities across 20 languages and currencies. The company has developed a web3 loyalty platform, accessible through any online source, which enables tokenized commerce. This platform allows customers to utilize their loyalty points across multiple brand partners, providing a seamless experience for users. Through its global distribution platform, Coras facilitates real-time access to ticket inventories, enabling suppliers and distributors from various sectors to collaborate effectively.

TerminusDB is an open-source in-memory graph database management system founded in Dublin, Ireland. It offers a comprehensive platform designed to transform inconsistent data sets into structured and integrated information. TerminusDB features a rich query language, WOQL, and provides a suite of revision control capabilities, including branch, merge, and time-travel functions. The platform facilitates data inference from business objects and relationships while enabling users to define governing rules and automate data migration for analytics. By focusing on structuring data to meet business needs, TerminusDB aims to reduce the complexity of data manipulation and enhance decision-making processes, ultimately supporting increased productivity and efficiency for its users.

Volograms Limited, based in Dublin, Ireland, specializes in volumetric video processing solutions that convert 2D videos into interactive 3D holograms. Founded in 2018, the company offers a mobile content creation platform called Volu, which leverages artificial intelligence to facilitate user-generated 3D content for augmented reality (AR) applications. This platform empowers smartphone users to easily create, share, and engage with immersive content from a single video recording. Volograms serves various sectors, including digital productions in virtual reality (VR), brand fan engagement, and enterprise applications such as professional education and training. Through its innovative technology, Volograms aims to make advanced content creation and communication accessible to a broader audience.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Siren is a provider of an investigative intelligence platform that integrates various data sources, including open, vendor, and classified information, to assist analysts and investigators in assessing risks and threats across sectors such as National Security, Public Safety, Fraud and Compliance, and Cyber Threats. The platform employs advanced artificial intelligence and search technologies, enabling users to conduct comprehensive investigations with features like temporal analysis, full-text search, and sophisticated visualizations. Siren’s patented technology facilitates easy access to analytics and reporting capabilities for diverse data types and large volumes. Recognized for its innovation, Siren received accolades such as inclusion in the Deloitte Technology Fast 50 and recognition as a Cool Vendor by Gartner in 2020.

iheed is an online medical education company that designs, develops, and delivers online accredited post-graduate education programs and degrees in partnership with medical universities. The company is built by doctors and healthcare professionals (HCPs) for doctors and healthcare professionals. iheed offers certificate, diploma, and Masters level education material to HCPs, packaged in modules. It utilizes technologies to offer the students a personalized, multi-sensory, multi-device learning experience suited to their learning style. Its programs and courses are adapted to the requirements of the healthcare system in different countries combining global best practice in medical training with local population healthcare needs. Its programs and courses are aimed at addressing the broad topics of healthcare need for frontline HCPs globally such as diabetes, women’s health, neurodegenerative diseases, cardiology, travel medicine, infection control, emergency medicine, disaster planning, research methodologies, practice management, nursing and pharmacology, and more. The iheed Online Learning Environment (OLE) is a next generation cloud-based platform for online education supports interactive case-based learning methods, provides practical real-world education for practicing clinicians, and helps them build up their clinical, professional, and communication skills in patient consultation. It offers a number of features aimed at tutors and administrators such as rubrics, Speedgrader, and Turnitin to support tutors in reviewing and grading student assignments, extensive reporting and analytics, targeted messaging, and various views that enable tutors to identify students that are not keeping up with the instruction or meeting pre-defined learning thresholds. Tutors of iheed’s Tutor Network hold weekly, bi-monthly, and per topic tutorial discussions via the web conferencing system within the iheed OLE platform to ensure students are aware of what is expected of them each week, and to discuss the key learning points in the context of the students’ day-to-day practices. iheed works in partnership with many medical universities, global health organizations, and technology companies, including University of Florida Health, Qualcomm, Hamad International Training Center, Johnson & Johnson, Health Human Resources Development Center, HP, Harvard School of Public Health, Tropical Medical Bureau, and Alliance Boots. Iheed was founded in 2010 and is based in Dublin, Ireland.

Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.

Coras specializes in enhancing ancillary revenue for various airlines, including Ryanair, Lufthansa, Wizz Air, and Air Asia, operating in over 50 countries and 350 cities across 20 languages and currencies. The company has developed a web3 loyalty platform, accessible through any online source, which enables tokenized commerce. This platform allows customers to utilize their loyalty points across multiple brand partners, providing a seamless experience for users. Through its global distribution platform, Coras facilitates real-time access to ticket inventories, enabling suppliers and distributors from various sectors to collaborate effectively.

Ambisense Ltd. is a Dublin-based company, founded in 2008, that specializes in designing and manufacturing gas monitoring instruments and networks for the Internet of Things (IoT) market. The company has been a leader in environmental innovation since 2014, focusing on optimizing environmental risk assessments for major infrastructure projects across various sectors, including industrial, oil and gas, and waste management. Its technology platform, Ambilytics, integrates IoT and machine learning solutions, utilizing information from field devices along with contextual data from sources such as weather, satellite, and geophysical data. This enables the development of machine learning models that uncover hidden relationships and patterns within the data, allowing clients to better forecast and predict the behavior of environmental pollutants.

Siren is a provider of an investigative intelligence platform that integrates various data sources, including open, vendor, and classified information, to assist analysts and investigators in assessing risks and threats across sectors such as National Security, Public Safety, Fraud and Compliance, and Cyber Threats. The platform employs advanced artificial intelligence and search technologies, enabling users to conduct comprehensive investigations with features like temporal analysis, full-text search, and sophisticated visualizations. Siren’s patented technology facilitates easy access to analytics and reporting capabilities for diverse data types and large volumes. Recognized for its innovation, Siren received accolades such as inclusion in the Deloitte Technology Fast 50 and recognition as a Cool Vendor by Gartner in 2020.

Petronics is a company that specializes in creating robotic pets for cats, with a focus on interactive play and exercise. Founded in 2014 and based in Champaign, Illinois, the company offers Mousr, a robotic toy designed to engage indoor cats in hunting-like activities. Mousr features advanced technology, including 360-degree vision, environmental sensing, and Bluetooth connectivity, which allows it to mimic the movements of prey. This innovative approach not only provides entertainment for cats but also helps address issues like obesity by encouraging active play.

Kastus is an award-winning surface innovation company founded in 2014 by John Browne, with its global headquarters and manufacturing based in Ireland. The company specializes in patented surface coating technology designed for glass and ceramics, which was developed to address the growing concerns over antibiotic-resistant infections and the spread of harmful microorganisms. Kastus' ISO-validated coatings have been proven to kill over 99% of bacteria, fungi, and viruses, including human coronavirus, making them particularly effective for enhancing touch hygiene across various products. In response to the COVID-19 pandemic, Kastus introduced antiviral and antimicrobial screen protectors to help businesses safely reopen from lockdown. The company continues to pursue innovative solutions to combat infection risks in indoor environments, backed by recent EU funding aimed at developing new protective technologies.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.